Avalyn Pharma Inc. · NASDAQ:AVLN
Rhodes Melissa sold 13,300 Avalyn Pharma Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 19, 2026
On Nov 17, 2026, Rhodes Melissa (Chief Operating Officer) sold 13,300 Avalyn Pharma Inc. shares at an average US$27.90 for US$371K under a trading plan, leaving 0 shares. Filed Nov 19, 2026 (Form 4).
- Sold
- 13,300 shares
- Price
- US$27.90 average (US$27.79 to US$29.23)
- Value
- US$371K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Option exercise | 13,300 | US$4.62 | 13,300 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 10,875 | US$27.79 | 2,425 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 2,025 | US$28.21 | 400 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 400 | US$29.23 | 0 | Direct |
Source
Download original · View original at SEC